{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T09:23:14Z","timestamp":1777195394413,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.nmd.2022.12.004","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T20:23:05Z","timestamp":1670876585000},"page":"145-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review"],"prefix":"10.1016","volume":"33","author":[{"given":"A.","family":"Pugliese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Nicocia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.nmd.2022.12.004_bib0001","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2022.12.004_bib0002","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis\u00a0: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2022.12.004_bib0003","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/WCO.0000000000000473","article-title":"Myasthenia gravis: new developments in research and treatment","author":"Evoli","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2022.12.004_bib0004","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0000000000000647","article-title":"Diagnosis and treatment of myasthenia gravis","volume":"31","author":"Mantegazza","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.004_bib0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mus.23964","article-title":"Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing","volume":"48","author":"Alkhawajah","year":"2013","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.nmd.2022.12.004_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.10.028","article-title":"Myasthenia gravis in the elderly","volume":"325","author":"Hellmann","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2022.12.004_bib0007","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mus.23645","article-title":"Double-seropositive myasthenia gravis","volume":"47","author":"Zouvelou","year":"2013","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.nmd.2022.12.004_bib0008","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1002\/mus.26040","article-title":"Double seropositive myasthenia gravis: a 5-year follow-up","volume":"57","author":"Zouvelou","year":"2018","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.nmd.2022.12.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577364","article-title":"AChR-and MuSK-positive myasthenia gravis: double trouble","volume":"348","author":"Zouvelou","year":"2020","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2022.12.004_bib0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4103\/0028-3886.68687","article-title":"Coexistent of muscle specific tyrosine kinase and acetylcholine receptor antibodies in a myasthenia gravis patient","volume":"58","author":"Suhail","year":"2010","journal-title":"Neurol India"},{"issue":"12","key":"10.1016\/j.nmd.2022.12.004_bib0011","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s00415-012-6661-9","article-title":"Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies","volume":"259","author":"Rajakulendran","year":"2012","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2022.12.004_bib0012","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.clinph.2006.07.265","article-title":"Myasthenia gravis with AChR and MuSK antibodies positivity: case report","volume":"118","author":"Al Saleh","year":"2007","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2022.12.004_bib0013","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2013.12.012","article-title":"AChR-myasthenia gravis switching to double-seropositive several years after the onset","volume":"267","author":"Zouvelou","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.nmd.2022.12.004_bib0014","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00415-015-7982-2","article-title":"Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis","volume":"263","author":"Jordan","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2022.12.004_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clineuro.2018.06.041","article-title":"Clinical characteristics of AChRAb and MuSKAb double seropositive myasthenia gravis patients","volume":"172","author":"Li","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nmd.2022.12.004_bib0016","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.05.011","article-title":"Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by D-penicillamine","volume":"250","author":"Poulas","year":"2012","journal-title":"J Neuroimmunol"},{"issue":"7","key":"10.1016\/j.nmd.2022.12.004_bib0017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ncpneuro0526","article-title":"Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan \u2019 s syndrome","volume":"3","author":"D\u00edaz-manera","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.nmd.2022.12.004_bib0018","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/01.wnl.0000267694.45244.f4","article-title":"Anti-musk antibody after thymectomy in a previously seropositive myasthenic child","volume":"69","author":"Saulat","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.004_bib0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2008.05.032","article-title":"MuSK-antibody positive myasthenia gravis: questions from the clinic","volume":"201-202","author":"Sanders","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.nmd.2022.12.004_bib0020","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00415-009-5215-2","article-title":"Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy","volume":"256","author":"AK\u00c6H","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2022.12.004_bib0021","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2015.12.016","article-title":"Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity","volume":"291","author":"Huijbers","year":"2016","journal-title":"J Neuroimmunol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622007283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622007283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:42Z","timestamp":1760775162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622007283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0960896622007283"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.12.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}